You are here: Industry Insights > Merck

News List

Breakthrough status for Pfizer/Merck’s avelumab combo pharmatimes
December 25, 2017
Merck and Pfizer’s avelumab has picked up its second breakthrough therapy status in the US, this time for use in combination with Inlyta for treatment-naïve patients with advanced renal cell carcinoma (RCC).
Merck agrees to manufacture viral vectors for bluebird bio pharmaceutical-technology
December 25, 2017
Merck has entered a commercial supply agreement with US-based bluebird bio to manufacture viral vectors for gene therapies.
3 Immuno-oncology therapeutics expected to Blast Off in 2018 biospace
December 25, 2017
Immuno-oncology therapeutics have revolutionized certain types of cancer treatments.
FDA Approves New Type 2 Diabetes Drug From Merck, Pfizer biospace
December 22, 2017
The U.S. Food and Drug Administration approved Merck’s and Pfizer’s Steglatro (ertugliflozin), a sodium-glucose co-transporter 2 (SGLT2)- inhibitor, that will square off against established drugs in the market.
With a Collaboration Deal in Place with Merck, Cue Biopharma Plans $60 Million IPO biospace
December 20, 2017
Cue BioPharma is on a roll, having recently signed a deal with Merck and is planning an initial public offering (IPO) to raise up to $60 million.
Merck to distribute all Avanti® Polar Lipids products outside of the U.S.A pharmaasia
December 18, 2017
Merck will employ its sales, marketing and e-commerce expertise to distribute Avanti® Polar Lipids products everywhere globally except for the U.S.A.
Merck to submit CDF proposal for cancer drug pharmaceutical-technology
November 30, 2017
The UK National Institute for Health and Care Excellence (NICE) has invited Merck to submit a Cancer Drugs Fund (CDF) proposal for its immunotherapy, avelumab, for the treatment of patients with Merkel cell carcinoma (MCC).
Merck places £1B bet on R&D in post-Brexit Britain fiercebiotech
November 28, 2017
Merck is set to invest about £1 billion ($1.3 billion) to open a drug discovery facility in London.
Merck Germany launches Merck Foundation expressbpd
November 24, 2017
Merck Germany launched Merck Foundation, a non-profit company established in June 2017 at the Fourth edition of their annual ‘Merck Africa Asia Luminary’ held in Cairo, Egypt.
Merck to suspend filing Ebola vaccine for FDA approval until next year fiercepharma
November 23, 2017
Despite a frantic effort to rush Ebola vaccines through testing during a deadly epidemic, Merck & Co. will fall short of its goal to file its candidate for FDA approval this year, the company confirmed Tuesday. Merck is now aiming for next year.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page